Composition and method for treating autoimmune hemolytic anemia
US7090865B2 · kind B2 · utility
0Cited by
2References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 27, 2002 |
| Grant date | Aug 15, 2006 |
| Priority date | — |
| Expiry date | Jul 31, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/675
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are a composition and method to treat or prevent antibody-induced anemia and particularly, autoimmune hemolytic anemia. The composition comprises a bisphosphonate and a pharmaceutically acceptable carrier. In a preferred embodiment, the composition comprises clodronate and a liposome carrier.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.